Safety, Tolerability and Pharmacokinetics of L608 in Healthy Adults

NCT05938946 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

64

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Arterial Hypertension

Interventions

DRUG: L608 Inhalation Solution
DRUG: Placebo solution

Sponsor

Pharmosa Biopharm Inc.

Collaborators

[object Object]